Comparison of Somatuline (BIM-23014) and somatostatin on endocrine and exocrine activities in the rat
β Scribed by Dr. Sylviane C. Moreau; William A. Murphy; David H. Coy
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 934 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We have studied the pharmacokinetics and the effects of BIM 23,014 (BIM), a new, long-acting octapeptide somatostatin analogue, on basal and stimulated GH secretion in normal men. BIM 250 micrograms sc significantly reduced a GHRH-induced increase in plasma GH. The continuous sc administration of BI
Exocrine and endocrine pancreatic function were studied simultaneously in the isolated perfused pancreas from rats fed a normal or an acarbose-containing diet (150 mg/100 g food) for 20 days. Body weight gain of acarbose-treated rats was slightly lower than that of control rats, despite a larger foo